Biotechnology Allogene Therapeutics Announces Preclinical Publication Highlighting Superiority of Healthy Donor-Derived Allogeneic CAR T Cells Over Patient-Derived Cells in Multiple Myeloma March 23, 2022
Biotechnology Target Hospitality and Big Lots have been highlighted as Zacks Bull and Bear of the Day March 23, 2022
Biotechnology Moore Kuehn, PLLC Encourages Investors of Axsome Therapeutics, Inc. To Contact Law Firm March 22, 2022
Biotechnology Strength Seen in Revance Therapeutics, Inc. (RVNC): Can Its 8.7% Jump Turn into More Strength? March 22, 2022
Biotechnology Positive Topline Results Announced from ADAPT-SC Study Evaluating Subcutaneous Efgartigimod Using ENHANZE® Drug Delivery Technology for Generalized Myasthenia Gravis March 22, 2022